IP Library Assignment 067131/0651
Patent Assignment
Reel/Frame 067131/0651

Omnibus Patent Security Release Agreement (Reel/Frame 057821/0800)

Recorded: 2024-04-17 Pages: 11
Assignor
THE BANK OF NEW YORK MELLON
Executed: 2024-04-11
Assignees
BAUSCH + LOMB IRELAND LIMITED
3013 LAKE DRIVE, CITYWEST BUSINESS CAMPUS, DUBLIN 24, D24PPT3, IRELAND
BAUSCH + LOMB CORPORATION
520 APPLEWOOD CRESCENT, VAUGHAN, L4K 4B4, CANADA
Covered Properties (13)
Photodynamic Therapy of Occult Age-Related Macular Degeneration
Patent: 8,034,803 →
Application: 10/072,272 →
Publication: US 2003/0087889
Compositions and Methods for Delivery of Photosensitive Drugs
Patent: 7,455,858 →
Application: 10/440,505 →
Publication: US 2004/0047913
Accommodating 360 Degree Sharp Edge Optic Plate Haptic Lens
Patent: 7,553,327 →
Application: 10/888,163 →
Publication: US 2005/0125057
Controlled release microparticles
Patent: 8,877,229 →
Application: 11/607,382 →
Publication: US 2007/0292475
"W" Accommodating Intraocular Lens
Patent: 7,763,070 →
Application: 11/940,169 →
Publication: US 2008/0154363
Synergistic Pharmaceutical Composition, Method of Making Same and Use of Same
Patent: 8,642,094 →
Application: 12/434,289 →
Publication: US 2009/0285915
Accommodating 360 Degree Sharp Edge Optic Plate Haptic Lens
Patent: 8,109,998 →
Application: 12/494,190 →
Publication: US 2009/0264999
Photodynamic Therapy for Conditions of the Eye
Patent: 9,226,917 →
Application: 13/140,411 →
Publication: US 2012/0041356
Photodynamic Therapy Laser
Patent: 9,211,214 →
Application: 13/426,470 →
Publication: US 2013/0253411
Activation of Innate and Adaptive Immune Responses by a Ginseng Extract
Patent: 9,050,313 →
Application: 13/846,267 →
Publication: US 2013/0295205
Photodynamic Therapy Laser
Patent: 9,949,877 →
Application: 14/872,248 →
Publication: US 2016/0074222
Ocular Drug Delivery Devices
Application: 16/241,558 →
Publication: US 2019/0133934
Grafted Polymer and Use Thereof
Application: 17/022,398 →
Publication: US 2021/0087384
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Intellectual Property Security Agreement Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Assignment of Assignor's Interest Sep 16, 2020
From: DIBELLA, JAMES ANTHONY; ALWASTHI, ALOK K.; RUSSELL, JADE J; MIS, MARK R.
To: BAUSCH HEALTH US, LLC
Reel/Frame 053787/0569 →
Assignment of Assignor's Interest Sep 16, 2020
From: BAUSCH HEALTH US, LLC
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 053787/0588 →
Assignment of Assignor's Interest Sep 16, 2020
From: KUMAR, KAUSHLENDRA
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 053787/0581 →
Security Interest May 20, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH + LOMB IRELAND LIMITED; BAUSCH HEALTH US, LLC; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056304/0581 →
Security Interest May 20, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH + LOMB IRELAND LIMITED; BAUSCH HEALTH US, LLC; MEDICIS PHARMACEUTICAL CORPORATION
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 056304/0556 →
Corrective Assignment to Correct the Second Inventor's Name Previously Recorded at Reel: 053787 Frame: 0569. Assignor(S) Hereby Confirms the Assignment. Jun 21, 2021
From: DIBELLA, JAMES ANTHONY, JR; AWASTHI, ALOK K.; RUSSELL, JADE J.; MIS, MARK R.
To: BAUSCH HEALTH US, LLC
Reel/Frame 057701/0071 →
Security Interest Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
Assignment of Assignor's Interest Jan 25, 2022
From: BAUSCH HEALTH IRELAND LIMITED
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 058755/0636 →
Security Interest Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
Intellectual Property Security Agreement Sep 8, 2022
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 061391/0172 →
Release of Security Interest in Specified Patents (Reel/Frame 056304/0556) Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 061776/0619 →
Omnibus Patent Security Release Agreement (Reel/Frame 060346/0705) Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 061848/0790 →
Assignment of Assignor's Interest Jan 13, 2023
From: BAUSCH HEALTH COMPANIES INC.
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 062375/0428 →
Assignment of Assignor's Interest Jan 13, 2023
From: VALEANT CANADA LP
To: BAUSCH HEALTH, CANADA INC.
Reel/Frame 062373/0488 →
Assignment of Assignor's Interest Jan 13, 2023
From: BAUSCH HEALTH, CANADA INC.
To: BAUSCH + LOMB CORPORATION
Reel/Frame 062374/0174 →
Change of Name Jan 13, 2023
From: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
To: BAUSCH HEALTH COMPANIES INC.
Reel/Frame 062389/0306 →
Assignment of Assignor's Interest Apr 17, 2023
From: BAUSCH HEALTH IRELAND LIMITED
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 063347/0248 →
Assignment of Assignor's Interest Apr 17, 2023
From: C&C VISION INTERNATIONAL LIMITED (IN VOLUNTARY LIQUIDATION)
To: VALEANT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 063346/0971 →
Change of Name Apr 17, 2023
From: VALEANT PHARMACEUTICALS IRELAND LIMITED
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 063347/0078 →
Assignment of Assignor's Interest Jun 28, 2023
From: HALLORAN, KEVIN JOHN
To: ATON PHARMA, INC.
Reel/Frame 064095/0350 →
Merger Jun 28, 2023
From: ATON PHARMA, INC.
To: PRINCETON PHARMA HOLDINGS, LLC
Reel/Frame 064095/0682 →